Aerovate Therapeutics, Inc.
USD2.68
+0.00 (+0.00%)
CEO
Timothy P. Noyes
IPO Date
2021-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.66
Prev. Close
$2.68
Day Low
$2.63
Day High
$2.77
52W Low
$2.63
52W High
$884.98
Market Cap
$0.08B
Volume
0.98M
| -1.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -69.0% | -59.3% | 0.01 | 7.04 | -7.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -40.6% | -38.1% | 0.01 | 16.90 | -13.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -13.3% | -13.1% | 0.00 | 68.37 | -12.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -326.8% | -203.8% | 0.00 | 2.64 | -58.0 |
| -8.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -14.0% | -12.4% | 0.00 | 9.01 | -3.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.9% | -14.3% | 0.00 | 10.31 | -2.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -3.4% | -3.2% | 0.00 | 32.01 | -7.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -7.1% | -6.8% | 0.01 | 20.93 | -3.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -20.2% | -17.9% | 0.01 | 8.78 | -3.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -26.2% | -22.2% | 0.01 | 6.51 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -25.5% | -21.7% | 0.01 | 6.65 | -9.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -18.6% | -16.0% | 0.01 | 7.04 | -7.7 |